Interactions between U-937 human macrophages and tyloxapol

Colloids and Surfaces B: Biointerfaces

Volumn 64, Issue 2, 2008, Pages 208-215

  Kuo, Jung hua Steven ^a   Lin, Yi Lin ^a   Tseng, Jo wen ^a  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Cell cycle; Macrophage; Mitochondrial membrane potential; Reactive oxygen species; Tyloxapol

Indexed keywords

CELL MEMBRANES; FLOW CYTOMETRY; HYDROGEN PEROXIDE; NEGATIVE IONS; PROTEINS;

CELL CYCLE; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; TYLOXAPOL;

MACROPHAGES;

ENDOTOXIN; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TYLOXAPOL;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DOSE INCREASE; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR INTERACTION; PRIORITY JOURNAL;

ANTIOXIDANTS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FORMAZANS; HUMANS; HYDROGEN PEROXIDE; INDICATORS AND REAGENTS; LIPOSOMES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OXIDOREDUCTASES; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; TIME FACTORS;

EID: 43849098250     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2008.01.024     Document Type: Article

References (24)

1. In: Reynolds J.E.F. (Ed). Martindale, The Extra Pharmacopoeia. 31st ed. (1996), Royal Pharmaceutical Society, London 1347
2. Serikov V.B., Glazanova T.V., Jerome E.H., Fleming N.W., Higashimori H., and Staub N.C. Inflammation 27 (2003) 175-190
3. Gursoy N., Garrigue J.S., Razafindratsita A., Lambert G., and Benita S. J. Pharm. Sci. 92 (2003) 2411-2418
4. Kukowska-Latallo J.F., Chen C., Eichman J., Bielinska A.U., and Baker J.R. Biochem. Biophys. Res. Commun. 14 (1999) 253-261
5. Yamamoto K., Shen B., Zarins C., and Scanu A.M. Arteriosclerosis 4 (1984) 418-434
6. Dechant K.L., and Faulds D. Drugs 42 (1991) 877-894
7. Staub N.C., Longworth K.E., Serikov V., Jerome E.H., and Elsasser T. J. Appl. Physiol. 90 (2001) 1788-1797
8. Thomassen M.J., Antal J.M., Divis L.T., and Wiedemann. Clin. Immunol. Immunopathol. 77 (1995) 201-205
9. Ghio A.J., Marshall B.C., Diaz J.L., Hasegawa T., Samuelson W., Povia D., Kennedy T.P., and Piantodosi C.A. Am. J. Respir. Crit. Care Med. 154 (1996) 783-788
10. Kuo J.H., Jan M.S., and Chiu H.W. Pharm. Res. 23 (2006) 1509-1516
11. Iles K.E., and Forman H.J. Immunol. Res. 26 (2002) 95-105
12. Nagata M. Curr. Drug Targets Inflamm. Allergy 4 (2005) 503-504
13. Napoli C., de Nigris F., and Palinski W. J. Cell. Biochem. 82 (2001) 674-682
14. Simon H.U., Haj-Yehia A., and Levi-Schaffer F. Apoptosis 5 (2000) 415-418
15. Ghio A.J., Fracica P.J., Young S.L., and Piantadosi C.A. J. Appl. Physiol. 77 (1994) 1217-1223
16. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., and Ueno K. Biol. Pharm. Bull. 19 (1996) 1518-1520
17. Rothe G., and Valet G. J. Leukoc. Biol. 47 (1990) 440-448
18. Emaus R.K., Grunwald R., and Lemasters J.J. Biochim. Biophys. Acta 850 (1986) 436-448
19. Freeman B.A., and Crapo J.D. Lab Invest. 47 (1982) 412-426
20. Zorov D.B., Juhaszova M., and Sollott S.J. Biochim. Biophys. Acta 1757 (2006) 509-517
21. Khaled A.R., Reynolds D.A., Young H.A., Thompson C.B., Muegge K., and Durum S.K. J. Biol. Chem. 276 (2001) 6453-6462
22. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.L., Petit P.X., and Kroemer G. J. Exp. Med. 181 (1995) 1661-1672
23. Smolewski P., Grabarek J., Halicka D., and Darzynkiewicz Z. J. Immunol. Methods 265 (2002) 111-121
24. Bragadin M., and Dell'Antone P. Arch. Environ. Contam. Toxicol. 30 (1996) 280-284